نتایج جستجو برای: anaplastic thyroid cancer

تعداد نتایج: 979026  

Journal: :Head & neck 2016
Paul Lennon Sandra Deady Maire L Healy Mary Toner John Kinsella Conrad I Timon James P O'Neill

BACKGROUND Anaplastic thyroid cancer has a median survival between 1.2 and 10 months. The purpose of our study was to evaluate the outcomes of patients with anaplastic thyroid cancer in Ireland. METHODS We carried out a retrospective analysis of the Irish National Cancer Database for patients with anaplastic thyroid cancer between 2000 and 2010. RESULTS Of a total of 64 patients (40 women, ...

Journal: :Endocrine-related cancer 2001
D Giuffrida H Gharib

BACKGROUND Clinically evident cardiac metastases from malignant neoplasms are uncommon. The frequency of thyroid metastasis to the heart is very low. To our knowledge, over the last 20 years only a few cases have been reported in the entire literature. Metastatic cardiac involvement occurs most often during the terminal stage. PATIENTS We present three cases of anaplastic thyroid cancer with ...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Quang T Luong James O'Kelly Glenn D Braunstein Jerome M Hershman H Phillip Koeffler

PURPOSE The histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), has multiple antitumor effects against a variety of human cancers. EXPERIMENTAL DESIGN We treated several anaplastic and papillary thyroid cancer cell lines with SAHA to determine if it could inhibit the growth of these cells in vitro and in vivo. RESULTS SAHA effectively inhibited 50% clonal growth of the an...

2014
Mingxu Guan Gaetano Romano Roberta Coroniti Earl E Henderson

Thyroid malignant neoplasm develops from follicular or parafollicular thyroid cells. A higher proportion of anaplastic thyroid cancer has an adverse prognosis. New drugs are being used in clinical treatment. However, for advanced thyroid malignant neoplasm such as anaplastic thyroid carcinoma, the major impediment to successful control of the disease is the absence of effective therapies. Oncol...

Journal: :Thyroid : official journal of the American Thyroid Association 2016
Cari M Kitahara Marjorie L McCullough Silvia Franceschi Sabina Rinaldi Alicja Wolk Gila Neta Hans Olov Adami Kristin Anderson Gabriella Andreotti Laura E Beane Freeman Leslie Bernstein Julie E Buring Francoise Clavel-Chapelon Lisa A De Roo Yu-Tang Gao J Michael Gaziano Graham G Giles Niclas Håkansson Pamela L Horn-Ross Vicki A Kirsh Martha S Linet Robert J MacInnis Nicola Orsini Yikyung Park Alpa V Patel Mark P Purdue Elio Riboli Kimberly Robien Thomas Rohan Dale P Sandler Catherine Schairer Arthur B Schneider Howard D Sesso Xiao-Ou Shu Pramil N Singh Piet A van den Brandt Elizabeth Ward Elisabete Weiderpass Emily White Yong-Bing Xiang Anne Zeleniuch-Jacquotte Wei Zheng Patricia Hartge Amy Berrington de González

BACKGROUND Greater height and body mass index (BMI) have been associated with an increased risk of thyroid cancer, particularly papillary carcinoma, the most common and least aggressive subtype. Few studies have evaluated these associations in relation to other, more aggressive histologic types or thyroid cancer-specific mortality. METHODS This large pooled analysis of 22 prospective studies ...

Journal: :Brazilian journal of otorhinolaryngology 2012
Débora Modelli Vianna Otávio Alberto Curioni Luciano José de Lemos França Diógenes Lopes de Paiva Bernardo Fontel Pompeu Rogério Aparecido Dedivitis Abrão Rapoport

UNLABELLED Thyroid cancer is the most common endocrine cancer, accounting for about 1% of all cancers. Sarcomas, lymphomas and metastases to the thyroid gland are rare and only with a handful of descriptions in the literature. OBJECTIVE To describe rare histological types of thyroid cancer found in a reference center. METHODS Medical chart review from admitted patients diagnosed with thyroi...

2017
Huabin Yin Tong Meng Lei Zhou Haiyan Chen Dianwen Song

In the past 2 decades, the incidence of thyroid cancer has been rapidly increasing worldwide. Anaplastic thyroid cancer (ATC) is the most lethal of all thyroid cancers and one of the most aggressive human carcinomas. SPC24 is an important component of the mitotic checkpoint machinery in the tumorigenesis and high levels of SPC24 have been found in colorectal and hepatocellular carcinomas, but i...

2012
XING-GUANG ZHANG XIAO-FENG LU XIU-MING JIAO BIN CHEN JIN-XIAO WU

The aim of this study was to observe the regulatory action of the polo-like kinase 1 (PLK1) gene in the invasion of anaplastic thyroid carcinoma cells and investigate its mechanisms. The expression of the PLK1 protein in 36 patients with anaplastic thyroid carcinoma was detected by immunohistochemical staining. siRNA against PLK1 was designed, synthesized and transfected into ARO cells. The eff...

Journal: :Endocrine-related cancer 2010
Dara O Kavanagh Marie McIlroy Eddie Myers Fiona Bane Thomas B Crotty E McDermott Arnold D Hill Leonie S Young

Epidemiological, clinical, and molecular studies suggest a role for oestrogen in thyroid cancer. How oestrogen mediates its effects and the consequence of it on clinical outcome has not been fully elucidated. The participation of coregulatory proteins in modulating oestrogen receptor (ER) function and input of crosstalk with the tyrosine kinase receptor HER2 was investigated. Oestrogen induced ...

2017
Shu-Fu Lin Jen-Der Lin Chuen Hsueh Ting-Chao Chou Chun-Nan Yeh Ming-Huang Chen Richard J. Wong

Heat shock protein 90 is a molecular chaperon that maintains the correct folding and function of multiple client proteins. The inhibition of heat shock protein 90, which leads to the simultaneous degradation of multiple proteins involved in oncogenic signaling pathways, has revealed an innovative strategy to treat a variety of cancer types. We evaluated the therapeutic effects of ganetespib, a ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید